Pain Medicine News’ editor, Donald Pizzi talks with David Craig,
PharmD, BCPS, a clinical pharmacist specialist and director of the Pain and
Palliative Care Specialty Residency at the H. Lee Moffitt Cancer Center and
Research Institute in Tampa, Florida about the FDA’s draft guidance for
manufacturers developing abuse-deterrent opioids.